Anton Gueth, Director at ANTARES PHARMA, INC. (ATRS), sold 25,000 shares at $4.41 ($110K) on 2013-08-01, disclosed to the SEC on 2013-08-05.
Scheduled sale ($110k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRS | BUY | 2014-08-13 | $10K | — | Filing → |
| ATRS | SELL | 2013-09-05 | $111K | — | Filing → |
| ATRS | SELL | 2013-07-03 | $104K | — | Filing → |